A detailed history of Mediolanum International Funds LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Mediolanum International Funds LTD holds 115,877 shares of LLY stock, worth $86 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
115,877
Previous 120,473 3.81%
Holding current value
$86 Million
Previous $102 Billion 0.67%
% of portfolio
1.41%
Previous 1.67%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $3.55 Million - $4.41 Million
-4,596 Reduced 3.81%
115,877 $102 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $36.5 Million - $45.8 Million
50,362 Added 71.83%
120,473 $102 Billion
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $41.5 Million - $55.5 Million
70,111 New
70,111 $54.6 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $705B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.